Fortis Healthcare

Stocks to Watch today, Dec 22: Varun Beverages, KEC International, PVR Inox, Rites, Tech M, and Crompton Greaves are some of the other stocks to watch today

Most open offers are for a minimum of an additional stake of 26 per cent and allow public shareholders an exit after the acquisition

Healthcare chain to invest Rs 840 crore to expand the facility's capacity to 300 beds, eyes over 1500 beds in the city by 2028

Analysts say IHH's play may include improving revenue per bed by lifting clinical mix

Fortis Healthcare has partnered with Ekana Group to manage a 550-bed greenfield hospital in Lucknow, expanding its Uttar Pradesh presence alongside its Noida and Greater Noida units

IHH arm NTK raises damages claim against Daiichi Sankyo to Rs 11,800 crore, alleging obstruction of Fortis Healthcare acquisition via stalled open offer

Wins bid for Rs 200 crore at December auction to acquire trademark

Average revenue per occupied bed of major health care companies grows

The company's revenue from operations rose to Rs 1,988 crore in Q2 FY25, a 12.3 per cent Y-o-Y increase from Rs 1,770 crore reported in Q2 FY24

The competition watchdog CCI on Tuesday approved Fortis Healthcare's proposal to acquire an additional 31.52 per cent stake in Agilus Diagnostics. Multi-speciality hospital chain Fortis Healthcare Ltd (FHL) is engaged in providing integrated healthcare delivery services like medicare, healthcare and diagnostics. The diagnostics services business of FHL is being undertaken primarily through Agilus. "Commission approves the acquisition of additional 31.52 per cent share capital of Agilus Diagnostics Ltd by Fortis Healthcare Ltd," according to a post by CCI on X. After the transaction, the shareholding of Fortis Healthcare Ltd (FHL) in Agilus will increase from 57.68 per cent to 89.2 per cent. In August, Fortis Healthcare announced that it will acquire a 31 per cent stake in Agilus Diagnostics for Rs 1,780 crore valuing Agilus at Rs 5,700 crore. The Competition Commission of India (CCI) has also cleared the proposed merger of Diliigent Power into DB Power, and the reorganisation of

Raghuvanshi provides an overview of the company's FY24 performance and expansion plans for FY25

The company's revenue from operations rose to Rs 1,786 crore in Q4 FY24, an 8.7 per cent Y-o-Y rise from Rs 1,643 crore reported in Q4 FY23

Fortis Healthcare Ltd on Thursday reported a 46.88 per cent increase in consolidated net profit at Rs 203.14 crore in the fourth quarter ended March 2024 on the back of higher revenue from its core business. The company had posted a consolidated net profit of Rs 138.3 crore in the same quarter a year ago, Fortis Healthcare said in a regulatory filing. Consolidated revenue from operations in the quarter under review stood at Rs 1,785.88 crore as against Rs 1,642.7 crore in the year-ago period, it added. Revenue from the core healthcare division was at Rs 1,489.78 crore in the fourth quarter as compared to Rs 1,350.98 crore in the year-ago period. Diagnostics division clocked a revenue of Rs 338.44 crore in Q4FY24 as against Rs 332.14 crore a year ago. Total expenses in the fourth quarter were higher at Rs 1,531.76 crore as compared to Rs 1,485.33 crore in the corresponding period of the preceding fiscal. The company said its board has recommended a final dividend of Re 1 per equit

Fortis Healthcare Ltd on Thursday reported a 46.88 per cent increase in consolidated net profit at Rs 203.14 crore in the fourth quarter ended March 2024 on the back of higher revenue from its core business. The company had posted a consolidated net profit of Rs 138.3 crore in the same quarter a year ago, Fortis Healthcare said in a regulatory filing. Consolidated revenue from operations in the quarter under review stood at Rs 1,785.88 crore as against Rs 1,642.7 crore in the year-ago period, it added. Revenue from the core healthcare division was at Rs 1,489.78 crore in the fourth quarter as compared to Rs 1,350.98 crore in the year-ago period. Diagnostics division clocked a revenue of Rs 338.44 crore in Q4FY24 as against Rs 332.14 crore a year ago. Total expenses in the fourth quarter were higher at Rs 1,531.76 crore as compared to Rs 1,485.33 crore in the corresponding period of the preceding fiscal. The company said its board has recommended a final dividend of Re 1 per equit

The COO position is being reassessed as leadership roles get recalibrated and leaders and boards want to keep their structure flat and nimble to make decisions faster than ever before

Fortis Hospital aims for an Earnings Before Interest, Taxes, Depreciation, and Amortisation (EBITDA) growth of about 20 per cent

'Every hospital now tracks length of stay closely. We cannot keep on increasing the critical care beds,' says Dr Bishnu Panigrahi, group head, medical strategy and operations, Fortis Healthcare

Nifty Healthcare has outperformed Nifty50 and some individual healthcare stocks have doubled investor wealth in FY24

Medanta, Rainbow Children Medicare, Shalby, Apollo Hospitals, Fortis Healthcare and newly listed GPT Healthcare fell 2-8 per cent in intra-day trade on BSE

On Oct, 16, Northern TK Venture filed a claim against the Japanese pharmaceuticals manufacturer stating it caused losses to the company by preventing it from proceeding with open offers